We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Increase in Papillary Thyroid Cancer Incidence Is Accompanied by Changes in the Frequency of the BRAF<sup>V600E</sup> Mutation: A Single-Institution Study.
- Authors
Kowalska, Aldona; Walczyk, Agnieszka; Kowalik, Artur; Pałyga, Iwona; Trybek, Tomasz; Kopczyński, Janusz; Kajor, Maciej; Chrapek, Magdalena; Pięciak, Liliana; Chłopek, Małgorzata; Góźdź, Stanisław; Kamiński, Grzegorz
- Abstract
Background: Thyroid cancer (TC) has one of the fastest increasing incidences worldwide and primarily involves papillary thyroid cancer (PTC). The BRAFV600E mutation is the most common genetic alteration identified in PTC. There are few data concerning an association between the rising incidence of PTC and the increasing prevalence of BRAF-positive cases. Environmental factors such as iodine intake may be responsible for the changing molecular features of PTC. The aim of this study was to evaluate probable variations in the frequency of the BRAFV600E mutation in PTC that were diagnosed at a single institution over 14 years in Poland, a country with a demonstrated improvement in iodine supplementation in the early 21st century. Methods: Time-dependent trends in the prevalence of the BRAFV600E mutation during three time periods (2000-2004, 2005-2009, and 2010-2013) were analyzed. The BRAF mutation was genotyped using direct sequencing, allele-specific polymerase chain reaction (PCR), and real-time PCR in 723 unselected cases of PTC that were diagnosed in 2000-2013. Trends in the clinicopathologic characteristics of all PTCs and BRAFV600E-positive PTCs were also analyzed. Results: The proportion of PTCs with mutations significantly increased over the study period (54.8% vs. 70.6%; p = 0.001). The median tumor size of all and BRAF-positive tumors decreased ( p = 0.008 and p = 0.001, respectively) and correlated with an increase in the proportion of all and mutated microcarcinomas ( p = 0.003 and p = 0.003, respectively). A decrease in all and mutated tumors between 2 and 4 cm was also observed ( p = 0.002 and p = 0.006, respectively). A significant decrease in tumors ≥4 cm in size was only observed in BRAF-positive cases ( p = 0.017). The proportion of classic PTC with BRAFV600E mutation was observed to increase (57.6% vs. 74.4%; p = 0.001) and was stable for the follicular variant of PTC ( p = 0.336). Conclusions: The prevalence of the BRAFV600Emutation increased significantly in PTCs diagnosed in the authors' institution. Improved detection and several causative factors, most likely environmental and changes in iodine intake, may contribute to the increasing occurrence of TC.
- Subjects
THYROID cancer; THYROID nodules; GENETIC mutation; GENETIC engineering; POLYMERASE chain reaction
- Publication
Thyroid, 2016, Vol 26, Issue 4, p543
- ISSN
1050-7256
- Publication type
Article
- DOI
10.1089/thy.2015.0352